DNER and cancer: Collectively, these findings demonstrate that BETi-treated cancer cells undergo GDH1-mediated glutamine metabolic remodeling to maintain energy homeostasis and viability, and blocking this adaptation process elicits energy crisis and synthetic lethality with BET inhibition.